Modelling the cost-effectiveness of PCSK9 inhibitors vs. ezetimibe through LDL-C reductions in a Norwegian setting
Peer reviewed, Journal article
![Thumbnail](/fhi-xmlui/bitstream/handle/11250/2446262/Korman_2017_Mod.pdf.jpg?sequence=5&isAllowed=y)
View/ Open
Date
2017Metadata
Show full item recordCollections
- Artikler [5061]
- Publikasjoner fra CRIStin FHI [7536]